Pilot Randomized Controlled Trial of Titrated Subcutaneous Ketamine in Older Patients with Treatment-Resistant Depression-Reference-Cited by-同舟云学术

Pilot Randomized Controlled Trial of Titrated Subcutaneous Ketamine in Older Patients with Treatment-Resistant Depression

Published:2017-11 Issue:11 Volume:25 Page:1199-1209
ISSN:1064-7481
Container-title:The American Journal of Geriatric Psychiatry
language:en
Short-container-title:The American Journal of Geriatric Psychiatry

Author:

George Duncan,Gálvez Verònica,Martin Donel,Kumar Divya,Leyden John,Hadzi-Pavlovic Dusan,Harper Simon,Brodaty Henry,Glue Paul,Taylor Rohan,Mitchell Philip B.,Loo Colleen K.

Funder

NSW Institute of Psychiatry

University of Barcelona

NARSAD

Publisher

Elsevier BV

Subject

Psychiatry and Mental health,Geriatrics and Gerontology

Reference29 articles.

1. Depression, chronic diseases, and decrements in health: results from the World Health Surveys;Moussavi;Lancet,2007

2. Efficacy of antidepressants for late-life depression: a meta-analysis and meta-regression of placebo-controlled randomized trials;Tedeschini;J Clin Psychiatry,2011

3. Depression in older adults;Fiske;Annu Rev Clin Psychol,2009

4. Neuromodulation therapies for geriatric depression;Gálvez;Curr Psychiatry Rep,2015

5. Ketamine administration in depressive disorders: a systematic review and meta-analysis;Fond;Psychopharmacology (Berl),2014

Cited by 92 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Is lack of goal-conflict-specific rhythmicity a biomarker for treatment resistance in generalised anxiety but not social anxiety or major depression?;Journal of Psychopharmacology;2024-09-02

2. Dépression résistante aux traitements chez les personnes âgées;NPG Neurologie - Psychiatrie - Gériatrie;2024-09

3. Fast-acting antidepressant-like effects of ketamine in aged male rats;Pharmacological Reports;2024-08-19

4. Rapid and long-lasting effects of subcutaneous esketamine on suicidality: An open-label study in patients with treatment-resistant depression;Journal of Psychiatric Research;2024-08

5. Subcutaneous ketamine reduces suicide risk and improves functioning in depression: A proof-of-concept study;Psychiatry Research;2024-07